NexgenRx Inc. (TSXV:NXG)
Canada · Delayed Price · Currency is CAD 0.6050
0.00 (0.00%)
At close: Aug 25, 2026
NexgenRx Financials Overview
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 19.34 | 17.93 | 16.48 | 13.85 | 12.78 | 11.84 |
Revenue Growth | 13.65% | 8.84% | 18.99% | 8.33% | 7.94% | 12.01% |
Gross Profit Gross Profit Growth | 16.42 | 14.93 | 13.12 | 10.82 | 10.18 | 9.81 |
Operating Income Operating Income Growth | 3.62 | 2.23 | 1.2 | -0.14 | 0.29 | 2.2 |
Net Income Net Income Growth | 2.37 | 1.06 | 0.42 | -0.53 | -0.02 | 4.02 |
Earnings Per Share EPS Growth | 0.03 | 0.01 | 0.01 | -0.01 | -0.00 | 0.05 |
EPS Growth | 206.88% | 180.00% | - | - | - | 86.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3.57 | 4.78 | 1.71 | 1.88 | 1.77 | 2.32 |
Total Debt Total Debt Growth | 0.28 | 0.37 | 0.53 | 0.46 | 0.43 | 0.4 |
Net Cash (Debt) Net Cash Growth | 3.29 | 4.41 | 1.17 | 1.41 | 1.33 | 1.92 |
Net Cash Growth | 93.80% | 276.44% | -17.18% | 6.03% | -30.33% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.04 | 0.06 | 0.02 | 0.02 | 0.02 | 0.03 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 3.25 | 4.98 | 1.15 | 1.28 | 1.07 | 3.82 |
Capital Expenditures CapEx Growth | -0.21 | -0.3 | -0.09 | -0.08 | -0.39 | -0.13 |
Free Cash Flow Free Cash Flow Growth | 3.05 | 4.68 | 1.06 | 1.2 | 0.68 | 3.7 |
Free Cash Flow Growth | 76.91% | 339.62% | -11.31% | 77.23% | -81.69% | 46.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 84.89% | 83.28% | 79.65% | 78.14% | 79.67% | 82.88% |
Operating Margin | 18.70% | 12.45% | 7.27% | -1.04% | 2.25% | 18.57% |
Pretax Margin | 16.94% | 10.79% | 6.23% | -2.20% | 1.05% | 16.97% |
Profit Margin | 12.23% | 5.90% | 2.53% | -3.83% | -0.18% | 33.93% |
FCF Margin | 15.75% | 26.10% | 6.46% | 8.67% | 5.30% | 31.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.015 | 0.015 | 0.010 | 0.010 | 0.010 |
Dividend Per Share Growth | 0% | 50.00% | 0% | 0% | - |
Dividend Yield | 2.46% | 3.83% | 3.89% | 5.16% | 4.35% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 19.68 | 26.87 | 46.95 | - | - | 7.00 |
P/FCF Ratio | 14.24 | 6.08 | 18.37 | 12.93 | 27.52 | 7.61 |
PS Ratio | 2.24 | 1.59 | 1.19 | 1.12 | 1.46 | 2.38 |